|
Feb 23
|
GSK plc (GSK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
|
|
Feb 21
|
GSK’s Sluggish Shares Seen at Risk of New Activist Campaign
|
|
Feb 19
|
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week (UPDATED)
|
|
Jan 29
|
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
|
|
Jan 29
|
GSK announces EMA accepted for review the MAA for depemokimab
|
|
Jan 29
|
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings
|
|
Jan 27
|
GSK and Oxford researchers to create cancer vaccine to stop disease developing
|
|
Jan 27
|
Trending tickers: Nvidia, Alphabet, Alibaba, Novo Nordisk and GSK
|
|
Jan 21
|
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer
|
|
Jan 20
|
Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?
|
|
Jan 18
|
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
|
|
Jan 17
|
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
|
|
Jan 16
|
Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential?
|
|
Jan 4
|
GSK’s Nucala Gains Approval in China for CRSwNP
|
|
Jan 3
|
GSK's Sinus Disease Drug Secures Approval In China
|
|
Dec 30
|
Can GSK plc (LON:GSK) Maintain Its Strong Returns?
|
|
Oct 15
|
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
|
|
Oct 14
|
GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
|
|
Oct 11
|
Jim Cramer Says GSK plc (GSK) ‘Goes Higher’
|
|
Oct 10
|
GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement
|